株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

止血迅速検査・ポイントオブケア (POC) - 医療機器のパイプライン評価

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 916558
出版日 ページ情報 英文 31 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
止血迅速検査・ポイントオブケア (POC) - 医療機器のパイプライン評価 Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019
出版日: 2019年11月01日 ページ情報: 英文 31 Pages
概要

当レポートでは、止血迅速検査・ポイントオブケア (POC) のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • 止血迅速検査・ポイントオブケア (POC) の概要

第3章 開発中の製品

  • 止血迅速検査・ポイントオブケア (POC) - パイプライン製品:開発段階別
  • 止血迅速検査・ポイントオブケア (POC) - パイプライン製品:地域別
  • 止血迅速検査・ポイントオブケア (POC) - パイプライン製品:規制別
  • 止血迅速検査・ポイントオブケア (POC) - パイプライン製品:承認予定日別

第4章 止血迅速検査・ポイントオブケア (POC) - 開発中のパイプライン製品:企業別

  • 止血迅速検査・ポイントオブケア (POC) 企業 - パイプライン製品:開発段階別
  • 止血迅速検査・ポイントオブケア (POC) - パイプライン製品:開発段階別

第5章 止血迅速検査・ポイントオブケア (POC) 企業と製品の概要

  • Atomo Diagnostics Pty Ltd
  • Carclo Diagnostic Solutions Ltd
  • Cascade Metrix LLC
  • Edan Instruments Inc
  • EKF Diagnostics Holdings Plc
  • Emosis SAS
  • Fraunhofer Institute for Cell Therapy and Immunology
  • Helena Laboratories Corp
  • Universal Biosensors Inc

第6章 止血迅速検査・ポイントオブケア (POC) - 最近の動向

第7章 付録

図表

List of Tables

  • Table 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
  • Table 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
  • Table 3: Hemostasis Rapid Tests & Point of Care (POC) P

List of Figures

  • Figure 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
  • Figure 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
  • Figure 3: Hemostasis Rapid Tests & Point of Care (PO
目次
Product Code: GDME0804EPD

GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables 3
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview 5

3 Products under Development 6

  • 3.1 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 6
  • 3.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory 7
  • 3.3 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path 8
  • 3.4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date 9

4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products under Development by Companies 10

  • 4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development 10
  • 4.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development 11

5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview 12

  • 5.1 Atomo Diagnostics Pty Ltd Company Overview 12
    • 5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 12
  • 5.2 Carclo Diagnostic Solutions Ltd Company Overview 13
    • 5.2.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
  • 5.3 Cascade Metrix LLC Company Overview 14
    • 5.3.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview 14
  • 5.4 Edan Instruments Inc Company Overview 15
    • 5.4.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • 5.5 EKF Diagnostics Holdings Plc Company Overview 16
    • 5.5.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.6 Emosis SAS Company Overview 17
    • 5.6.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview 17
  • 5.7 Fraunhofer Institute for Cell Therapy and Immunology Company Overview 18
    • 5.7.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.8 Helena Laboratories Corp Company Overview 19
    • 5.8.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.9 Universal Biosensors Inc Company Overview 26
    • 5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview 26

6 Hemostasis Rapid Tests & Point of Care (POC) - Recent Developments 27

  • 6.1 Apr 08, 2019: Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge 27
  • 6.2 Nov 22, 2018: EMOSIS reinforces its Intellectual Property and scientific expertise 27

7 Appendix 28

  • 7.1 Methodology 28
  • 7.2 About GlobalData 31
  • 7.3 Contact Us 31
  • 7.4 Disclaimer 31
Back to Top